p53 Activation With Navtemadlin Boosts T-Cell Killing of Melanoma
Navtemadlin-driven p53 activation pushed human T cells toward central memory differentiation, cutting exhaustion markers and boosting melanoma killing after 40 hours in lab assays.
Topic
Car T Cell Therapy
Topic